Provided by Tiger Fintech (Singapore) Pte. Ltd.

Voyager Therapeutics

3.16
+0.03000.96%
Post-market: 3.160.00000.00%16:54 EDT
Volume:338.68K
Turnover:1.06M
Market Cap:174.45M
PE:-2.80
High:3.20
Open:3.11
Low:3.07
Close:3.13
Loading ...
Nov 09, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2020

Major Issues Report

8-K - Current report
Sep 15, 2020

Major Issues Report

8-K - Current report
Aug 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2020

Major Issues Report

8-K - Current report
Aug 03, 2020

Major Issues Report

8-K - Current report
Jun 09, 2020

Major Issues Report

8-K - Current report
May 06, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 06, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 19, 2020

Major Issues Report

Current report, items 1.01, 2.03, and 9.01
Mar 05, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Mar 03, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 03, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 03, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Major Issues Report

Current report, items 5.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 11, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 11, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals